Table 1

Patient demographics and clinical characteristics

CharacteristicsUT patientsPT patients
JMDC database n=19 428MDV database
n=24 820
JMDC database
n=21 480
MDV database
n=65 601
Follow-up, days, median (IQR)929 (635–1345)942 (675–1356)980 (671–1446)1027 (715–1521)
Age at index date, years, mean (SD)51.7 (9.9)67.6 (11.8)54.4 (9.2)65.9 (12.0)
Gender: male, n (%)14 042 (72.3)15 093 (60.8)15 779 (73.5)40 160 (61.2)
Multiple medications*, mean (SD)2.0 (4.0)3.0 (2.2)2.3 (3.1)3.3 (2.0)
Charlson Comorbidity Index, mean (SD)2.2 (1.5)2.5 (2.3)2.5 (1.6)2.6 (2.2)
Comorbidities
 Hypertension (% pts)47.870.158.371.3
 Hyperlipidaemia (% pts)39.870.050.067.2
 Dementia (% pts)0.21.90.22.0
 Diabetic nephropathy (% pts)3.718.16.115.7
  • *Number of drugs prescribed (by three-digit Anatomical Therapeutic Chemical Classification System).

  • JMDC, Japan Medical Data Center; MDV, Medical Data Vision; PT, previously treated; pts, patients; UT, untreated.